Trials / Completed
CompletedNCT00095511
Aripiprazole in Patients With Acute Mania
A Multicenter, Randomized, Double-Blind, Placebo Controlled Study of Aripiprazole Monotherapy in the Treatment of Acutely Manic Patients With Bipolar I Disorder
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 615 (planned)
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this trial is to test the safety \& efficacy of aripiprazole in patients with Bipolar Mania for a period of at least 12 weeks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | aripiprazole |
Timeline
- Start date
- 2004-06-01
- Primary completion
- 2007-05-01
- Completion
- 2007-05-01
- First posted
- 2004-11-08
- Last updated
- 2013-11-11
Locations
38 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00095511. Inclusion in this directory is not an endorsement.